Enrico N De Toni
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
Zitzmann K, Brand S, De Toni E, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 2007; 67:5025-32.
May 15, 2007SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
May 15, 2007Cancer Res 2007; 67:5025-32
Zitzmann Kathrin, Brand Stephan, De Toni Enrico N, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H H D, Auernhammer Christoph J
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Zitzmann K, De Toni E, Brand S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology 2007; 85:54-60.
Feb 19, 2007The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Feb 19, 2007Neuroendocrinology 2007; 85:54-60
Zitzmann Kathrin, De Toni Enrico N, Brand Stephan, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H D, Auernhammer Christoph J